We would like to place cookies on your computer to improve the experience of using our website. You may block cookies from this site but parts of the site will not work. To find out more about the cookies we use and how to delete them, see our cookies policy.
 
 
 

Online Seminar: The Health of Biopharma - Trends in Investments and Exits

 
Analytics; Life Science
May 09, 2011 Posted by:

Join our panel of experts on biopharma valuations and venture capital investment in this free Web seminar replay, where they discuss the results of SVB Analytics' latest research findings. Our panel presents and discusses a range of data on operating performance, venture funding and valuations, and exit activity.

See the Web seminar replay [PLAYBACK]
Download the presentation (PDF)
SVB Capital: Private Life Science M&A Analysis (PDF) 

Among the topics we will discuss:

  • A Venture Capital perspective on early and late stage investments in the biopharma sector
  • Recent data on exit multiples, and time-and capital-to-exit
  • SVB Analytics' perspective on biopharma valuations
  • Trends in operating performance

Speakers:

Jon Norris, Managing Director, Silicon Valley Bank (moderator)
Garheng Kong, MD, PhD, General Partner, Sofinnova Ventures
Ashraf Hebela, Head of Prod Management, SVB Analytics
Dan Zaelit, Research Associate, SVB Analytics

0 comments

Comment

Not a Member?
Register now and join discussions in the SVB Professional network. Best of all, it's FREE.

Register Login to Comment

Terms of Service | Privacy Policy
 
Ashraf Hebela
Ashraf Hebela, CFA
Dir, Enterprise Bus Analytics
Silicon Valley Bank
Location: Menlo Park, CA
Phone: 415.764.4754
Contact Me
View Profile
Content Subscription
Subscribe to Analytics
Subscribe to Life Science
 

Silicon Valley Bank is registered in England and Wales at 41 Lothbury, London EC2R 7HF, UK under No. FC029579. Silicon Valley Bank is authorised and regulated by the California Department of Financial Institutions and the United States Federal Reserve Bank; authorised by the Prudential Regulation Authority with number 577295; and subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details about the extent of our regulation by the Prudential Regulation Authority are available from us on request. Silicon Valley Bank is a subsidiary of SVB Financial Group, a Delaware corporation and is an affiliate of SVB Financial Group UK Limited. SVB Financial Group UK Ltd is registered in England and Wales at 41 Lothbury, London EC2R 7HF, UK under No. 5572575 and is authorised and regulated by the Financial Conduct Authority, with reference number 446159. SVB Financial Group and its subsidiary Silicon Valley Bank are members of the Federal Reserve System and Silicon Valley Bank is a member of the FDIC.

Silicon Valley Bank is covered by the Financial Services Compensation Scheme and by the Financial Ombudsman Service. In relation to the Financial Services Compensation Scheme, please ensure that you review the important information on depositor preference that affects clients of Silicon Valley Bank in the UK.

 
Equal Housing Lender © 2013 SVB Financial Group · Member Federal Reserve System · Member Nasdaq: SIVB
Privacy Policy · Terms of Use · About SVB · Careers · Media · Investor Relations · Feedback
 
Please wait...